Clinical trials are designed to add to medical knowledge and most importantly, the results of these trials can make a difference in the care and treatment of Sjögren’s patients. A clinical trial is important because it contributes to the advancement of science. It provides the participants an opportunity to receive potential benefit from a drug, medical device or procedure or even a lifestyle change such as diet or exercise. The Sjögren’s Foundation is fully committed to the development of new therapeutics that will treat the entire disease, not just one symptom.
Click here to stay up to date on clinical trial and patient recruitment.
The items on this page provide you with:
- Information about participating in clinical trials, including a video
- A State-by-State listing of actively enrolling clinical trials from corporations providing support to the Sjögren’s Foundation
- Other websites listing clinical trials, including easy instruction to navigate the clinicaltrials.gov site.
The following links will provide you with additional knowledge about clinical trials, what's involved and what to expect:
Watch this presentation from our 2022 National Patient Conference. Clinical Trials: What Every Patient Should Know presented by Dr. Herbert Baraf (Accompanying Slides)
- All About Clinical Trials and Sjögren’s
- What to know about Clinical Trials and Sjögren’s
- Clinical Trials 101 (PDF - 106 KB)
- Clinical Trials: Getting Involved (PDF - 104 KB
Below is a listing of active Sjögren’s Clinical trials from companies supporting the Foundation’s mission. These listings are enrolling patients:
This is not an all inclusive list - for additional trials please use the links at the bottom of the page.
Santa Monica
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Orrin Troum, MD
Providence St. John's Health Center
2336 Santa Monica Blvd Ste 207
Santa Monica, CA 90404
Contact: Donna Cruz
Phone: (310) 449-1999
Email: donna [dot] cruz [at] providence [dot] org
Denver
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Christopher Antolini, MD
Denver Arthritis Clinic
200 Spruce Street Suite 100
Denver, CO 80230
Contact: Kaitlyn Arce
Phone: (303) 394-2828
Email: karce [at] dacdenver [dot] com
Clearwater
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Robert Levin, MD
Clinical Research of West Florida
2147 NE Coachman Road
Clearwater, FL 33765
Contact: Megan Arsenault
Phone: (727) 466-0078
Email: marsenault [at] crwf [dot] com
Augusta
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Elena Schiopu, MD
Augusta University
1120 15th St
Augusta, GA 30912
Contact: Aileen Lopez
Phone: (706) 721-1075
Email: ailopez [at] augusta [dot] edu
Skokie
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Robert Hozman, MD
Clinic of Robert Hozman/Clinical Investigation Specialists Inc.
4709 Golf Road
Skokie, IL 60076
Contact: Qusai Abdallah
Phone: (847) 599-2492
Email: qusai [dot] z [dot] abdallah [at] gmail [dot] com
Kansas City
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Ghaith Noaiseh, MD
University of Kansas Medical Center
3901 Rainbow Blvd.
Kansas City, KS 60160
Contact: Jill Case
Phone: (913) 588-0653
Email: jcase2 [at] kumc [dot] edu
Baton Rouge
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Saravanan Thiagarajan, MD
Ochsner Health Center - Baton Rouge
10310 The Grove Blvd.
Baton Rouge, LA 70836
Contact: Stephanie Fontenot
Phone: (225) 761-5978
Email: stephanie [dot] fontenot [at] ochsner [dot] org
Monroe
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Jyothi Mallepalli, MD, FACR
Arthritis and Diabetes Clinic
3402 Magnolia Cv
Monroe, LA 71203
Contact: Jessica Calhoun
Phone: (318) 812-1250
Email: jessicacalhoun3402 [at] gmail [dot] com
Baltimore
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Thomas Grader-Beck, MD, PhD
Johns Hopkins Medicine - Jerome L. Greene Sjögren's Center
5200 Eastern Ave Ste 4100 Rm 413
Baltimore, MD 21224-2746
Contact: Freena Chaudrhy
Phone: (410) 550-6492
Email: fchaudh4 [at] jhu [dot] edu
Bethesda
Blake M Warner, D.D.S
National Institute of Dental and Craniofacial Research
NIH Clinical Center - On the Metro red line (Medical Center stop)
Bethesda, Maryland
STUDY # 20-D-0131
Contact: Sasha Clary
Email: sasha [dot] clary [at] nih [dot] gov (sasha[dot]clary[at]nih[dot]gov)
Phone: (301) 529 -7924
Click here to learn more about Study #20-D-0131
En Español
Boston
Study #00002230
Click here for more information
Dr. Addy Alt-Holland and Dr. Mabi Singh
Tufts University School of Dental Medicine
1 Kneeland Street
Boston, MA 02111
Contact Name: Tiffany Bairos, Lead Coordinator
Phone: (617) 636-2408
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Pedram Hamrah, MD, FACS
Tufts Medical Center
Department of Ophthalmology
Boston, MA 02111
Contact: Karaghan Curran
Phone: (617) 636-1051
Email: kcurran3 [at] tuftsmedicalcenter [dot] org
Eagan
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
David Ridley, MD
St. Paul Rheumatology
2854 Hwy. 55, Ste. 190
Eagan, MN 55121
Contact: Zsofia Czegledi
Phone: (651) 361-8667
Email: zsofia [at] sprdrem [dot] com
Summit
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Elliot Rosenstein, MD
Institute for Rheumatic & Autoimmune Diseases, Overlook Medical Center
33 Upper Overlook Rd # 211
Summit, NJ 07901
Contact: Shakeema Funchess
Phone: (908) 598-7940
Email: shakeemaa [dot] funchess [at] atlantichealth [dot] org
Albuquerque
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Lance Rudolph, MD
New Mexico Clinical Research Osteoporosis
300 Oak St NE
Albuquerque, NM 87106
Contact: Devona Martinez
Phone: (505) 855-5505
Email: dmartinez [at] nmbonecare [dot] com
Mineola
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Steve Carsons, MD
NYU Langone Hospital - Long Island
101 Mineola Blvd
Mineola, NY 11501
Contact: Melissa Allman
Phone: (516) 663-9582
Email: malkiekaminsky [at] gmail [dot] com
New York City
CEQUA Phase 4
Sjögren’s Dry Eye Trial
J. Rocco Robilotto, OD, PhD
Center for Ophthalmic and Vision Research
133 E 54th St., Suite 200
Midtown East, New York, NY 10022
Contact: Alena Koickal
Phone: (212) 650-4888
Email: akoickal [at] ea-ny [dot] com (akoickal[at]ea-ny[dot]com)
Click here to learn more
Duncansville
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Alan Kivitz, MD
Altoona Center for Clinical Research
175 Meadowbrook Ln
Duncansville, PA 16635
Contact: Heather Breon
Phone: (814) 693-0300
Email: heatherbreon [at] altoonaresearch [dot] com
San Juan
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Oscar Soto-Raices, MD
Mindful Medical Research
576 Cesar Gonzalez Ave
San Juan, PR 00918
Contact: William Moreno
Phone: (787) 765-9034
Email: wmoreno [at] mmr-pr [dot] com
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Gregorio Cortes-Maisonet, MD
GCM Medical Group
62 Calle Jose Marti
San Juan, PR 00917
Contact: Luis Martinez Miranda
Phone: (787) 936-2100
Email: lmiranda [at] gcmmedical [dot] com
Jackson
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Jacob Aelion, MD
West Tennessee Research Institute
369 North Parkway
Jackson, TN 38305
Contact: Kim Smith
Phone: (731) 633-0119
Email: ksmith [at] arthritisclinic [dot] org
Allen
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Megha Patel-Banker, MD
Arthritis & Rheumatology Research Institute, PLLC
981 TX-121 Suite #3150
Allen, TX 75013
Contact: Guadalupe Cindo
Phone: (972) 798-8553
Email: l [dot] cindo [at] dfwarthritis [dot] com
Plano
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Fehmida Zahabi-Unwala, MD
Trinity Universal Research Associates
4105 West Spring Creek Parkway
Plano, TX 75024
Contact: Joseph Rimla
Phone: (217) 793-8341
Email: rimla [dot] joseph [at] yahoo [dot] com
Seattle
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Kwanghoon Bobby Han, MD
University of Washington Medical Center
1959 NE Pacific Street
Seattle, WA 98195
Contact: Megan Tran
Phone: (206) 616-5330
Email: megant99 [at] medicine [dot] washington [dot] edu
Spokane
Deucravacitinib (IM011-1069) Phase 3- Bristol Myers Squibb
Sjögren’s Clinical Trial (Systemic)
Click here to learn more
Jeffrey Butler, MD
Arthritis Northwest
105 W 8th Ave Ste 6080
Spokane, WA 99204
Contact: Terri Cone
Phone: (509) 838-6500
Email: tcone [at] arthritisnw [dot] com
Below are additional links that will help you find clinical trials in your area:
The NIH Clinical Research Trials and You website provides general information on participating in clinical research, with a focus on NIH-funded research.
MedlinePlus is a Web-based health information service of the National Library of Medicine.
FDA is responsible for ensuring the safety and effectiveness of drugs, vaccines, and other medical products. Read more about clinical trials and the drug development process on the FDA’s website.
ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals. To find trials related to Sjögren's:
Click the link to clinicaltrials.gov
On the LEFT: check the recruiting box to limit to trials actively recruiting THEN click APPLY
On the TOP: click the "on map" tab to see map of US
Click individual states to see available recruiting trials
CenterWatch.com Clinical Trial Listing Service provides patients with unbiased information on clinical trials, with a clinical trial database that contains thousands of currently enrolling trials. Information on drugs and new medical therapies are available to review. CenterWatch also provides patients with health and educational resources about clinical trials and other health information.